PETMED EXPRESS, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $274.1M | $247.6M | $272.3M | $303.6M | $284.1M | $283.4M |
| Cost of Revenue | — | $157.8M | $189.3M | $171.1M | $195.3M | $219.3M | $202.9M | $188.1M |
| Gross Profit | $50.2M | $69.1M | $84.8M | $76.5M | $76.9M | $84.3M | $81.2M | $95.3M |
| Gross Margin | 28.1% | 30.5% | 30.9% | 30.9% | 28.3% | 27.8% | 28.6% | 33.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $50.7M | $38.6M | $55.2M | $41.7M | $31.1M | $29.7M | $25.3M | $24.8M |
| Operating Income | $-58.7M | $-1.5M | $-8.2M | $6.1M | $24.3M | $30.5M | $31.0M | $46.2M |
| Operating Margin | -32.8% | -0.7% | -3.0% | 2.4% | 8.9% | 10.1% | 10.9% | 16.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-57.4M | $-587.0K | $-6.3M | $7.4M | $24.2M | $31.0M | $33.9M | $49.1M |
| Income Tax Expense | $-73.0K | $5.7M | $1.2M | $2.3M | $5.5M | $7.0M | $8.0M | $11.4M |
| Net Income | $-57.3M | $-6.3M | $-7.5M | $5.1M | $18.7M | $23.9M | $25.9M | $37.7M |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.1% | 6.9% | 7.9% | 9.1% | 13.3% |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 |
| Shares Outstanding (Basic) | 20.9M | 20.6M | 20.4M | 20.3M | 20.2M | 20.1M | 20.0M | 20.5M |
| Shares Outstanding (Diluted) | 20.9M | 20.6M | 20.4M | 20.3M | 20.4M | 20.1M | 20.1M | 20.5M |
| Dividends Per Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 | $1.08 | $1.06 |